AU2002222145A1 - Particulate inhalation carrier - Google Patents
Particulate inhalation carrierInfo
- Publication number
- AU2002222145A1 AU2002222145A1 AU2002222145A AU2214502A AU2002222145A1 AU 2002222145 A1 AU2002222145 A1 AU 2002222145A1 AU 2002222145 A AU2002222145 A AU 2002222145A AU 2214502 A AU2214502 A AU 2214502A AU 2002222145 A1 AU2002222145 A1 AU 2002222145A1
- Authority
- AU
- Australia
- Prior art keywords
- particulate inhalation
- inhalation carrier
- carrier
- particulate
- inhalation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Otolaryngology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0030074.9A GB0030074D0 (en) | 2000-12-08 | 2000-12-08 | Particulate inhalation carrier |
GB0030074 | 2000-12-08 | ||
PCT/GB2001/005436 WO2002045682A1 (en) | 2000-12-08 | 2001-12-10 | Particulate inhalation carrier |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002222145A1 true AU2002222145A1 (en) | 2002-06-18 |
Family
ID=9904780
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002222145A Abandoned AU2002222145A1 (en) | 2000-12-08 | 2001-12-10 | Particulate inhalation carrier |
Country Status (6)
Country | Link |
---|---|
US (1) | US20040062719A1 (en) |
EP (1) | EP1339388A1 (en) |
JP (1) | JP2004517834A (en) |
AU (1) | AU2002222145A1 (en) |
GB (1) | GB0030074D0 (en) |
WO (1) | WO2002045682A1 (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030055026A1 (en) | 2001-04-17 | 2003-03-20 | Dey L.P. | Formoterol/steroid bronchodilating compositions and methods of use thereof |
JP2005506323A (en) * | 2001-09-05 | 2005-03-03 | ベクトゥラ・リミテッド | Functional powder for oral delivery |
JP2006516531A (en) | 2002-08-21 | 2006-07-06 | ノートン ヘルスケアー リミテッド | Inhalation composition |
TWI359675B (en) | 2003-07-10 | 2012-03-11 | Dey L P | Bronchodilating β-agonist compositions |
GB0327723D0 (en) | 2003-09-15 | 2003-12-31 | Vectura Ltd | Pharmaceutical compositions |
DE102004048390A1 (en) * | 2004-10-01 | 2006-04-06 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | New powder inhalants based on modified lactose mixtures as adjuvant |
DE102004048389A1 (en) * | 2004-10-01 | 2006-04-06 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Modification of surfaces of lactose as adjuvant for use with powder inhalants |
JP4878463B2 (en) * | 2005-09-13 | 2012-02-15 | ホソカワミクロン株式会社 | Pharmaceutical preparation containing peptide hormone-encapsulated nanoparticles and method for producing the same |
DE102006030166A1 (en) * | 2006-06-29 | 2008-01-10 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | temper |
WO2008134817A1 (en) * | 2007-05-03 | 2008-11-13 | The University Of Sydney | Composite carriers for dry powder inhalation therapy |
GB0714134D0 (en) | 2007-07-19 | 2007-08-29 | Norton Healthcare Ltd | Dry-powder medicament |
EP2560611B1 (en) * | 2010-04-21 | 2018-01-03 | Chiesi Farmaceutici S.p.A. | "process for providing particles with reduced electrostatic charges" |
JOP20120023B1 (en) | 2011-02-04 | 2022-03-14 | Novartis Ag | Dry powder formulations of particles that contain two or more active ingredients for treating obstructive or inflammatory airways diseases |
SG11201507286QA (en) * | 2013-03-15 | 2015-10-29 | Pearl Therapeutics Inc | Methods and systems for conditioning of particulate crystalline materials |
EP2821061B1 (en) * | 2013-07-01 | 2017-12-20 | Arven Ilac Sanayi Ve Ticaret A.S. | Novel inhalation formulations |
LT3191081T (en) | 2014-09-09 | 2020-07-10 | Vectura Limited | Formulation comprising glycopyrrolate, method and apparatus |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5519237A (en) * | 1978-07-27 | 1980-02-09 | Toa Iyakuhin Kogyo Kk | Crystalline lactose with high beta-lactose content and diluent comprising it |
GB9001635D0 (en) * | 1990-01-24 | 1990-03-21 | Ganderton David | Aerosol carriers |
GB9501841D0 (en) * | 1995-01-31 | 1995-03-22 | Co Ordinated Drug Dev | Improvements in and relating to carrier particles for use in dry powder inhalers |
JPH11349475A (en) * | 1998-06-03 | 1999-12-21 | Dainippon Pharmaceut Co Ltd | Intraoral disintegrant and its production |
-
2000
- 2000-12-08 GB GBGB0030074.9A patent/GB0030074D0/en not_active Ceased
-
2001
- 2001-12-10 WO PCT/GB2001/005436 patent/WO2002045682A1/en not_active Application Discontinuation
- 2001-12-10 JP JP2002547468A patent/JP2004517834A/en active Pending
- 2001-12-10 US US10/433,435 patent/US20040062719A1/en not_active Abandoned
- 2001-12-10 EP EP01999355A patent/EP1339388A1/en not_active Withdrawn
- 2001-12-10 AU AU2002222145A patent/AU2002222145A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2004517834A (en) | 2004-06-17 |
US20040062719A1 (en) | 2004-04-01 |
WO2002045682A1 (en) | 2002-06-13 |
EP1339388A1 (en) | 2003-09-03 |
GB0030074D0 (en) | 2001-01-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG123530A1 (en) | Disk carrier | |
AU2001284668A1 (en) | Carrier tape | |
AU2002211949A1 (en) | Particulate trap | |
AU2002223028A1 (en) | Inhaler | |
AU2001246542A1 (en) | Catalyst constituent | |
AU2001272815A1 (en) | Baby carrier | |
AU2002222145A1 (en) | Particulate inhalation carrier | |
AU2001268750A1 (en) | Flushed-seal respirator | |
AU6847300A (en) | Exhaust volume | |
AU2001261562A1 (en) | Magnetic carrier particles | |
AU2001276511A1 (en) | Respirators | |
GB0020616D0 (en) | Particulates | |
AU2002322834A1 (en) | Disk carrier | |
AU2001259756A1 (en) | Magnetic carrier particles | |
AU2343901A (en) | Baby carrier | |
AU2001269744A1 (en) | Rivet carrier | |
AU2001294274A1 (en) | Antibody inhibiting VPLF activity | |
AU2001238089A1 (en) | Particulate distributor | |
AU2001262014A1 (en) | Baby carrier | |
PL111932U1 (en) | Hand carrier | |
AU6857200A (en) | Parallel rule | |
AU2000279670A1 (en) | Bind carrier | |
GB0117453D0 (en) | Carrier | |
AUPQ699600A0 (en) | Carrier | |
AU2001278854A1 (en) | Pet carrier |